395 related articles for article (PubMed ID: 15698637)
1. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
Porritt MJ; Batchelor PE; Howells DW
Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
[TBL] [Abstract][Full Text] [Related]
2. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
[TBL] [Abstract][Full Text] [Related]
3. Injury induced c-Jun expression and phosphorylation in the dopaminergic nigral neurons of the rat: correlation with neuronal death and modulation by glial-cell-line-derived neurotrophic factor.
Vaudano E; Rosenblad C; Björklund A
Eur J Neurosci; 2001 Jan; 13(1):1-14. PubMed ID: 11134999
[TBL] [Abstract][Full Text] [Related]
4. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
5. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
7. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Van Kampen JM; McGeer EG; Stoessl AJ
Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
[TBL] [Abstract][Full Text] [Related]
9. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.
Beck KD; Valverde J; Alexi T; Poulsen K; Moffat B; Vandlen RA; Rosenthal A; Hefti F
Nature; 1995 Jan; 373(6512):339-41. PubMed ID: 7830767
[TBL] [Abstract][Full Text] [Related]
10. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.
Hyman C; Hofer M; Barde YA; Juhasz M; Yancopoulos GD; Squinto SP; Lindsay RM
Nature; 1991 Mar; 350(6315):230-2. PubMed ID: 2005978
[TBL] [Abstract][Full Text] [Related]
11. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
12. Chronic supranigral infusion of BDNF in normal and MPTP-treated common marmosets.
Pearce RK; Costa S; Jenner P; Marsden CD
J Neural Transm (Vienna); 1999; 106(7-8):663-83. PubMed ID: 10907726
[TBL] [Abstract][Full Text] [Related]
13. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
Janson AM; Fuxe K
Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
[TBL] [Abstract][Full Text] [Related]
14. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
Szot P; White SS; Veith RC; Rasmussen DD
Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
[TBL] [Abstract][Full Text] [Related]
15. Infusion of iron into the rat substantia nigra: nigral pathology and dose-dependent loss of striatal dopaminergic markers.
Sengstock GJ; Olanow CW; Menzies RA; Dunn AJ; Arendash GW
J Neurosci Res; 1993 May; 35(1):67-82. PubMed ID: 7685399
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
17. Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy.
Kastner A; Herrero MT; Hirsch EC; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA; Agid Y
Ann Neurol; 1994 Aug; 36(2):206-14. PubMed ID: 7914399
[TBL] [Abstract][Full Text] [Related]
18. Re-expression of glia-derived nexin/protease nexin 1 depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra.
Scotti AL; Monard D; Nitsch C
J Neurosci Res; 1994 Feb; 37(2):155-68. PubMed ID: 7908698
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury.
Skaper SD; Negro A; Facci L; Dal Toso R
J Neurosci Res; 1993 Mar; 34(4):478-87. PubMed ID: 8097267
[TBL] [Abstract][Full Text] [Related]
20. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats.
Shults CW; Matthews RT; Altar CA; Hill LR; Langlais PJ
Exp Neurol; 1994 Feb; 125(2):183-94. PubMed ID: 8313937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
